Evicenter
MarkdownMedical informationP&T meetings
Cretostimogene grenadenorepvec (CG0070)

BCG-unresponsive high-risk non-muscle-invasive bladder cancer

Manufacturer
CG Oncology
Launch
Not announced
Last updated
161 sources

Product information and disease descriptionProduct descriptionProduct information

Co-prescribed/Concomitant therapies

7 evidence topics · 4 sources

Dwell times of the pretreatment agent and cretostimogene